More on KNSA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (10/27/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Kiniksa Pharmaceuticals Ltd. (NQ:KNSA)
Delayed: 76.73 -4.06 (5.03%)
Prev. Close $80.79  
Open$80.16 
52 Wk High$ 
52 Wk Low$ 
Day High$80.22 
Day Low$76.58 
P/E N/A  
EPS$ 
Volume576,438 


Oct 22, 2026 04:29 PM Form 8-K Kiniksa Pharmaceuticals For: Oct 17
Oct 22, 2026 04:01 PM Kiniksa Pharmaceuticals to Report Third Quarter 2026 Financial Results on October 27, 2026
Oct 18, 2026 08:00 PM U.S. biotech SMids: Q3 earnings preview
Sep 30, 2026 06:23 AM Wells Fargo Assumes Kiniksa (KNSA) at Overweight
Sep 4, 2026 04:01 PM Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference
Aug 21, 2026 04:35 PM Form 4 Kiniksa Pharmaceuticals For: Aug 19 Filed by: Quart Barry D
Aug 7, 2026 04:01 PM Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
Aug 4, 2026 04:40 PM Form 4 Kiniksa Pharmaceuticals For: Aug 01 Filed by: Levy Richard S
Jul 31, 2026 04:35 PM Form 4 Kiniksa Pharmaceuticals For: Jul 29 Filed by: Cole G Bradley
Jul 30, 2026 06:39 AM Kiniksa (KNSA) PT Raised to $90 at Goldman Sachs
View All Articles

Entities mentioned with KNSA

View All Entities